Key Record Dates
ClinicalTrials.gov Identifier: | NCT01422486 |
---|---|
Brief Title: | Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome |
First Submitted : | August 18, 2011 |
First Submitted that Met QC Criteria : | August 22, 2011 |
First Posted : | August 24, 2011 (Estimate) |
Last Update Submitted that Met QC Criteria : | November 20, 2013 |
Last Update Posted : | November 25, 2013 (Estimate) |